Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE (DD-MM-YYYY)
01-04-2007
REPORT TYPE
ABSTRACT:Human (hFOB 1.19) and murine (MC3T3-E1) osteoblasts grew for extended periods (up to 10 months) in a specialized bioreactor. Over time the cells formed multilayers and a collagenous matrix with mineralized nodules and small chips of "bone". The number of cell layers in the bone-like tissue peaked at about 30 to 60 days and then declined. This change was reflected in the cell morphology. Wth time, the osteoblasts transitioned from multilayer cuboidal cells to flat osteocyte-like cells. We characterized the response of MC3T3-E1 bone-like tissue at various stages of maturity to metastatic human MDA-MB-231 breast cancer cells using a variety of approaches. The cancer cells attached, grew, and penetrated the matrix. Within 2 days of coculture, the cancer cells replicated and organized into linear files. Close inspection of both 2D optical sections and 3D reconstructions revealed concomitant remodeling of the tissue. Over 3 days of co-culture, cuboidal osteoblasts became elongated and aligned themselves with cancer cells. The osteoblasts responded with production of IL-6, a characteristic osteoblast inflammatory stress cytokine. These data support our idea that the bioreactor will serve as a useful in vitro model to study the interaction of metastatic breast cancer cells and osteoblasts.
SUBJECT TERMSNone provided.